Cargando…

Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer

Dependence on the glutamine pathway is increased in advanced breast cancer cell models and tumors regardless of hormone receptor status or function. While 70% of breast cancers are estrogen receptor positive (ER+) and depend on estrogen signaling for growth, advanced ER+ breast cancers grow independ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demas, Diane M., Demo, Susan, Fallah, Yassi, Clarke, Robert, Nephew, Kenneth P., Althouse, Sandra, Sandusky, George, He, Wei, Shajahan-Haq, Ayesha N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688514/ https://www.ncbi.nlm.nih.gov/pubmed/31428575 http://dx.doi.org/10.3389/fonc.2019.00686

Ejemplares similares

Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 Inhibitors
por: Fallah, Yassi, et al.
Publicado: (2021)

Glutamine metabolism and the unfolded protein response in MYC-driven breast cancer
por: Shajahan-Haq, Ayesha, et al.
Publicado: (2014)

MYC-Driven Pathways in Breast Cancer Subtypes
por: Fallah, Yassi, et al.
Publicado: (2017)

MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer
por: Shajahan-Haq, Ayesha N, et al.
Publicado: (2014)

Modeling breast cancer proliferation, drug synergies, and alternating therapies
por: He, Wei, et al.
Publicado: (2023)

Inhibition of DNA Repair Pathways and Induction of ROS Are Potential Mechanisms of Action of the Small Molecule Inhibitor BOLD-100 in Breast Cancer
por: Bakewell, Suzanne, et al.
Publicado: (2020)

Mathematical modelling of breast cancer cells in response to endocrine therapy and Cdk4/6 inhibition
por: He, Wei, et al.
Publicado: (2020)

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
por: Ni, Rui, et al.
Publicado: (2023)

Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
por: Scheidemann, Erin R., et al.
Publicado: (2021)

EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer
por: Shajahan-Haq, Ayesha N., et al.
Publicado: (2017)

Glutamine synthetase expression rescues human dendritic cell survival in a glutamine-deprived environment
por: Schoeppe, Robert, et al.
Publicado: (2023)

Application of Metabolomics in Drug Resistant Breast Cancer Research
por: Shajahan-Haq, Ayesha N., et al.
Publicado: (2015)

Rhophilin-2 Upregulates Glutamine Synthetase by Stabilizing c-Myc Protein and Confers Resistance to Glutamine Deprivation in Lung Cancer
por: Xiao, Dakai, et al.
Publicado: (2021)

Therapeutic Potential of Glutamine Pathway in Lung Cancer
por: Tang, Enyu, et al.
Publicado: (2022)

Glutamine metabolism in cancers: Targeting the oxidative homeostasis
por: Gong, Tengfang, et al.
Publicado: (2022)

Glutamine metabolism and radiosensitivity: Beyond the Warburg effect
por: Alden, Ryan S., et al.
Publicado: (2022)

Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth
por: Scalise, Mariafrancesca, et al.
Publicado: (2017)

Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment
por: He, Songjiang, et al.
Publicado: (2022)

PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer
por: Lynce, Filipa, et al.
Publicado: (2018)

Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast Cancer
por: Reinert, Tomas, et al.
Publicado: (2017)

Decrease of Intracellular Glutamine by STF-62247 Results in the Accumulation of Lipid Droplets in von Hippel-Lindau Deficient Cells
por: Johnson, Mathieu, et al.
Publicado: (2022)

Precision Medicine in Hormone Receptor-Positive Breast Cancer
por: Nasrazadani, Azadeh, et al.
Publicado: (2018)

Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women
por: Lu, Yen-Shen, et al.
Publicado: (2021)

Differential glutamine metabolism in the tumor microenvironment – studies in diversity and heterogeneity: A mini-review
por: Claiborne, Michael D., et al.
Publicado: (2022)

Crosstalk between arginine, glutamine, and the branched chain amino acid metabolism in the tumor microenvironment
por: Wetzel, Tanner J., et al.
Publicado: (2023)

New progress of glutamine metabolism in the occurrence, development, and treatment of ovarian cancer from mechanism to clinic
por: Yang, Xiaojing, et al.
Publicado: (2022)

Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in China
por: Wu, Yun, et al.
Publicado: (2021)

Comparative review of pharmacological therapies in individuals with HER2-positive advanced breast cancer with focus on hormone receptor subgroups
por: Umemneku-Chikere, Chinyereugo M., et al.
Publicado: (2022)

A Personalized, Dynamic Physical Activity Intervention Is Feasible and Improves Energetic Capacity, Energy Expenditure, and Quality of Life in Breast Cancer Survivors
por: Ballinger, Tarah J., et al.
Publicado: (2021)

Metabolic Constants and Plasticity of Cancer Cells in a Limiting Glucose and Glutamine Microenvironment—A Pyruvate Perspective
por: Otto, Angela M.
Publicado: (2020)

Relevance of the TRIAP1/p53 axis in colon cancer cell proliferation and adaptation to glutamine deprivation
por: Nedara, Kenza, et al.
Publicado: (2022)

Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival
por: Li, Hui, et al.
Publicado: (2023)

The Prognosis of Single Hormone Receptor-Positive Breast Cancer Stratified by HER2 Status
por: Zhao, Hengqiang, et al.
Publicado: (2021)

Aberrant epigenetic and transcriptional events associated with breast cancer risk
por: Marino, Natascia, et al.
Publicado: (2022)

4-Hydroxyphenylpyruvate Dioxygenase-Like Protein Promotes Pancreatic Cancer Cell Progression and Is Associated With Glutamine-Mediated Redox Balance
por: Ye, Xianglai, et al.
Publicado: (2021)

A Novel Prognostic Nomogram for Predicting Survival of Hormone Receptor-Positive and HER2 Negative Advanced Breast Cancer Among the Han-Population
por: Zhu, Yimin, et al.
Publicado: (2022)

The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature
por: Botticelli, Andrea, et al.
Publicado: (2022)

Case Report: Resolution of radiation pneumonitis with androgens and growth hormone
por: Yen, Allen, et al.
Publicado: (2022)

Real-World First-Line Treatment Patterns and Outcomes in Hormone Receptor-Positive Advanced Breast Cancer Patients: A Multicenter, Retrospective Study in China
por: Chen, Zhanhong, et al.
Publicado: (2022)

Adipocytic Glutamine Synthetase Upregulation via Altered Histone Methylation Promotes 5FU Chemoresistance in Peritoneal Carcinomatosis of Colorectal Cancer
por: Zhang, Xuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2a2pk6b3bau5oqcqagpr6llib5